Events in the Series

IPF logo

Advancing Novel Targets, Defining & Securing Translational Efficacy & Overcoming Clinical Challenges to Develop More Effective & Disease-Modifying IPF Drugs

Returning 2023


22138 Interstitial Lung Disease Drug Development Summit logo

Deepen Scientific Understanding of Inflammatory & Fibrotic ILDs, Investigate Biomarkers to Stratify Trial Populations and Identify Endpoints Which are Likely to Predict Clinical Success in Your Next Clinical Trial

Returning in April 2023


HW220619 25586 6th Obesity & NASH Drug Development Summit NEW COLOURS FINAL

Harness Advances in GLP-1 Receptor Agonists to Drive Drug-Based Management of Obesity

Accelerate Towards Validation of Non-Invasive Biomarkers to Establish Efficacy

Combination Therapy in Obesity & NASH & Holistic Approaches to Metabolic Syndrome